Crossmark

Full-length and N-terminally truncated recombinant interleukin-38 variants are similarly inefficient in antagonizing interleukin-36 and interleukin-1 receptors

Crossref DOI link: https://doi.org/10.1186/s12964-025-02035-z

Published Online: 2025-01-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Diaz-Barreiro, Alejandro

Talabot-Ayer, Dominique

Huard, Arnaud

Cereghetti, Gea

Tonacini, Jenna

Maillasson, Mike

Francés-Monerris, Antonio

Mortier, Erwan

Palmer, Gaby
License Information

Text and Data Mining valid from 2025-01-20

Version of Record valid from 2025-01-20
More Information

Article History

Received: 25 July 2024

Accepted: 8 January 2025

First Online: 20 January 2025

Declarations

:

: Skin biopsies were taken from healthy adults undergoing surgery at the Department of Plastic and Reconstructive Surgery of the Geneva University Hospitals in Switzerland. This study was conducted according to the Declaration of Helsinki, and approved by the local ethics committee of the University Hospitals of Geneva (protocol number 2017 − 00700). Written informed consent was obtained from each individual.

: not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below